Articles

Long-term eradication of extranodal natural killer/T-cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells in vivo

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan;Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Center for Translational Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan
Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan;Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
Vol. 105 No. 3 (2020): March, 2020 https://doi.org/10.3324/haematol.2019.223511